Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCorvus Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Corvus Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Jun 11, 2026van den Broek RichardDirector15,000Stock Option (Right to Buy)$166.8KGrant / award
Jun 11, 2026Thompson Peter A.Director, 10% Owner15,000Stock Option (Right to Buy)$166.8KGrant / award
Jun 11, 2026Grais LindaDirector15,000Stock Option (Right to Buy)$166.8KGrant / award
Jun 11, 2026CLARK IAN TDirector15,000Stock Option (Right to Buy)$166.8KGrant / award
Jun 11, 2026Moore David ScottDirector15,000Stock Option (Right to Buy)$166.8KGrant / award
Jun 11, 2026Moore David ScottDirector21,700Common Stock$241.3KBuy
May 18, 2026MILLER RICHARD A MDPresident and CEO6,932Common Stock$85.3KBuy
Apr 23, 2026Chan Andrew C.Director30,000Stock Option (Right to Buy)$502.2KGrant / award
Jan 28, 2026Thompson Peter A.Director, 10% Owner210,000Common Stock$5.3MOption exercise
Dec 4, 2025LEA LEIVChief Financial Officer400,000Stock Option (Right to Buy)$3.7MGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$10.53Close · Oct 9, 2026